Latest Intellectual Property News

Nyrada’s experimental drug NYR-BI03 shows promising cardioprotective and anti-arrhythmic effects in animal models, reinforcing its potential as a treatment for acute myocardial infarction.

Aurora Labs has reached a critical design freeze milestone under its Australian Defence Force contract, advancing its novel 3D-printed propulsion system towards testing and validation phases.

EcoGraf Limited has been granted a second Australian patent for its HFfree® purification technology, reinforcing its position in the sustainable battery materials market. This patent extends protection for its innovative graphite purification process critical to lithium-ion battery anode production and recycling.

Nanoveu Limited spotlighted its cutting-edge ultra-low-power AI semiconductor technology and strategic collaborations at the Pitt Street Research Semiconductor Conference 2025, signaling a bold push into edge AI markets.

Vection Technologies has landed a $1.2 million grant to lead an innovative XR and AI digital twin project aimed at transforming real-time product intelligence in food and beverage manufacturing.

Synertec Corporation reports a 7.7% revenue increase in FY25 Q3, highlights robust Powerhouse technology performance during extreme weather, and secures a US patent for its LNG Custody Transfer System.

Next Science Limited has successfully had a derivative complaint dismissed in Florida, while continuing legal action against former employees for breach of post-employment restraints.

Anagenics Limited has completed a significant restructuring to simplify operations and issued 35 million shares to FOS Capital as part of this process. The company confirms its going concern status and outlines plans for organic and acquisitive growth over the next year.

BluGlass Limited has launched a $6 million Share Purchase Plan (SPP) offering new shares with attaching options to eligible shareholders, aiming to fund the scale-up of its visible laser production and support ongoing product development.

Anagenics Limited reported a cash outflow of $424K for Q3 2025 but maintains robust liquidity with $1.48 million in available funding, supported by a mix of secured and unsecured loans.

BlinkLab Limited has raised A$7.66 million through a well-supported placement to accelerate FDA regulatory trials for its autism and ADHD diagnostic platforms, leveraging its innovative smartphone-based technology.

ClearVue Technologies has secured its first commercial rooftop contract in Sydney’s CBD, supplying innovative solar glass for the City Tattersalls Club redevelopment to boost sustainability and energy efficiency.